Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 7 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Discovery of RGT-018: a Potent, Selective and Orally Bioavailable SOS1 Inhibitor for KRAS-driven Cancers
Fei Xiao, Kailiang Wang,Xinjuan Wang,Huijuan Li,Zhilong Hu, Xiaoming Ren, Wei Huang, Teng Feng,Lili Yao,Jing Lin, Chunlai Li, Zhuanzhuan Zhang,
Molecular cancer therapeutics (2024)
Cited0Views0WOSBibtex
0
0
Cryo-EM structures reveal two allosteric inhibition modes of PI3KαH1047R involving a re-shaping of the activation loop
Xiuliang Huang, Kailiang Wang, Jing Han, Xiumei Chen, Zhenglin Wang, Tianlun Wu, Bo Yu, Feng Zhao,Xinjuan Wang,Huijuan Li,Zhi Xie,Xiaotian Zhu,
Structure (London, England : 1993)no. 7 (2024): 907-917.e7
Cited0Views0WOSBibtex
0
0
Abstract 477: Discovery of RGT-018: A potent, selective and orally bioavailable SOS1 inhibitor for mutant KRAS-driven cancers
Fei Xiao, Kailiang Wang,Xinjuan Wang,Huijuan Li,Zhilong Hu, Wei Huang, Xiaoming Ren, Tao Feng,Lili Yao,Jing Lin, Chunlai Li,Liufeng Mei,
CANCER RESEARCHno. 7_Supplement (2023): 477-477
Cited0Views0Bibtex
0
0
Author Statistics

#Papers: 7

#Citation: 1

H-Index: 1

G-Index: 1

Sociability: 4

Diversity: 0

Activity: 0

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn